Elevated SRSF9 levels promote the alternative splicing of NFATc4 pre-mRNA and the activation of hypertrophic gene expression, thereby activating the NFAT signaling pathway, leading to cardiac hypertrophy and remodeling, and ultimately promoting the occurrence and development of heart failure [50]. Here, SRSF9 is linked to heart failure.